U.S. Physical Therapy (NYSE: USPH) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its peers? We will compare U.S. Physical Therapy to related businesses based on the strength of its profitability, valuation, institutional ownership, earnings, dividends, risk and analyst recommendations.
This is a summary of current recommendations and price targets for U.S. Physical Therapy and its peers, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|U.S. Physical Therapy||0||2||2||0||2.50|
|U.S. Physical Therapy Competitors||59||327||512||9||2.52|
This table compares U.S. Physical Therapy and its peers’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|U.S. Physical Therapy||5.29%||13.37%||6.63%|
|U.S. Physical Therapy Competitors||3.55%||3.42%||4.26%|
Insider and Institutional Ownership
99.8% of U.S. Physical Therapy shares are owned by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by institutional investors. 3.1% of U.S. Physical Therapy shares are owned by insiders. Comparatively, 10.8% of shares of all “Hospitals, Clinics & Primary Care Services” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
U.S. Physical Therapy pays an annual dividend of $0.80 per share and has a dividend yield of 1.1%. U.S. Physical Therapy pays out 58.0% of its earnings in the form of a dividend. As a group, “Hospitals, Clinics & Primary Care Services” companies pay a dividend yield of 1.0% and pay out 42.4% of their earnings in the form of a dividend. U.S. Physical Therapy has increased its dividend for 6 consecutive years.
Valuation and Earnings
This table compares U.S. Physical Therapy and its peers top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|U.S. Physical Therapy||$356.55 million||$20.55 million||51.74|
|U.S. Physical Therapy Competitors||$1.06 billion||-$22.56 million||780.70|
U.S. Physical Therapy’s peers have higher revenue, but lower earnings than U.S. Physical Therapy. U.S. Physical Therapy is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Risk and Volatility
U.S. Physical Therapy has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, U.S. Physical Therapy’s peers have a beta of 0.87, indicating that their average stock price is 13% less volatile than the S&P 500.
U.S. Physical Therapy peers beat U.S. Physical Therapy on 8 of the 15 factors compared.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company’s segment is made up of various clinics within partnerships. The Company primarily operates through subsidiary clinic partnerships, in which it owns a general partnership interest and a limited partnership interest, and the managing therapists of the clinics owns the remaining limited partnership interest in the clinics. The Company operates 562 physical therapy clinics in 42 states. There are approximately 380 clinics operated under Clinic Partnerships and over 100 operated as Company-owned Facilities. In addition to its owned clinics, it also manages physical therapy facilities for third parties, primarily physicians, with over 29 third-party facilities under management.
What are top analysts saying about U.S. Physical Therapy? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for U.S. Physical Therapy and related companies.